Project Number 2R44AG060843-02 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Targeting tau for the development of novel Alzheimer's disease therapeutics Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator LARSEN, GLENN Principal Investigator First Name GLENN Principal Investigator Last Name LARSEN Awardee Organization AQUINNAH PHARMACEUTICALS, INC. Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PA-19-272: PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed FY Overall Cost $1,475,961 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
